DSpace Repository

Development of a Novel Class of Pyridazinone Derivatives as Selective

Show simple item record

dc.contributor.author Alagoz, MA
dc.contributor.author Oh, JM
dc.contributor.author Zenni, YN
dc.contributor.author Ozdemir, Z
dc.contributor.author Abdelgawad, MA
dc.contributor.author Naguib, IA
dc.contributor.author Ghoneim, MM
dc.contributor.author Gambacorta, N
dc.contributor.author Nicolotti, O
dc.contributor.author Kim, H
dc.contributor.author Mathew, B
dc.date.accessioned 2022-10-05T13:00:56Z
dc.date.available 2022-10-05T13:00:56Z
dc.date.issued 2022
dc.identifier.uri http://hdl.handle.net/11616/62207
dc.description.abstract Sixteen compounds (TR1-TR16) were synthesized and evaluated for their inhibitory activities against monoamine oxidase A and B (MAOs). Most of the derivatives showed potent and highly selective MAO-B inhibition. Compound TR16 was the most potent inhibitor against MAO-B with an IC50 value of 0.17 mu M, followed by TR2 (IC50 = 0.27 mu M). TR2 and TR16 selectivity index (SI) values for MAO-B versus MAO-A were 84.96 and higher than 235.29, respectively. Compared to the basic structures, the para-chloro substituent in TR2 and TR16 increased the inhibitory activity of MAO-B. TR2 and TR16 were reversible MAO-B inhibitors that were competitive, with K-i values of 0.230 +/- 0.004 and 0.149 +/- 0.016 mu M, respectively. The PAMPA method indicated that compounds TR2 and TR16 had the tendency to traverse the blood-brain barrier. Docking investigations revealed that lead compounds were beneficial for MAO-B inhibition via association with key as well as selective E84 or Y326 residues, but not for MAO-A inhibition via interaction primarily driven by hydrophobic contacts. In conclusion, TR2 and TR16 are therapeutic prospects for the management of multiple neurodegenerative diseases.
dc.description.abstract C1 [Alagoz, Mehmet Abdullah; Zenni, Yaren Nur; Ozdemir, Zeynep] Inonu Univ, Fac Pharm, Dept Pharmaceut Chem, TR-44280 Malatya, Turkey.
dc.description.abstract [Oh, Jong Min; Kim, Hoon] Sunchon Natl Univ, Dept Pharm, Sunchon 57922, South Korea.
dc.description.abstract [Oh, Jong Min; Kim, Hoon] Sunchon Natl Univ, Res Inst Life Pharmaceut Sci, Sunchon 57922, South Korea.
dc.description.abstract [Abdelgawad, Mohamed A.] Jouf Univ, Coll Pharm, Dept Pharmaceut Chem, Sakaka 72341, Al Jouf, Saudi Arabia.
dc.description.abstract [Naguib, Ibrahim A.] Taif Univ, Coll Pharm, Dept Pharmaceut Chem, POB 11099, Taif 21944, Saudi Arabia.
dc.description.abstract [Ghoneim, Mohammed M.] AlMaarefa Univ, Fac Pharm, Dept Pharm Practice, Ad Diriyah 13713, Saudi Arabia.
dc.description.abstract [Gambacorta, Nicola; Nicolotti, Orazio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy.
dc.description.abstract [Mathew, Bijo] Amrita Vishwa Vidyapeetham, Dept Pharmaceut Chem, Amrita Sch Pharm, AIMS Hlth Sci Campus, Kochi 682041, Kerala, India.
dc.source MOLECULES
dc.title Development of a Novel Class of Pyridazinone Derivatives as Selective


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record